Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results

Galmed Pharma (GLMD) Reports In-Line Q4 EPS

May 2, 2022 7:08 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.30), in-line with the analyst estimate of ($0.30).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More